Geneva, Aug. 5 -- International Clinical Trials Registry received information related to the study (ISRCTN14542909) titled 'Evaluation of a cosmetic treatment to help reduce hair loss' on July 18.
Study Type: Interventional
Study Design:
Double-blinded randomized controlled trial (Treatment, Safety, Efficacy)
Primary Sponsor: CELL ACELL
Condition:
Female subject with telogen effluvium
Skin and Connective Tissue Diseases
Intervention:
The product under investigation is a cosmetic spray.
Half of the recruited subjects are randomized to receive the active product, while the other half receive the placebo. A restricted randomization list is generated by the Study Director using PASS 11 software (PASS, LLC, Kaysville, UT, USA) and the...